Skip to main content
Top
Published in: Journal of Genetic Counseling 6/2015

Open Access 01-12-2015 | Original Research

Feasibility of an Assessment Tool for Children’s Competence to Consent to Predictive Genetic Testing: a Pilot Study

Authors: Irma M. Hein, Pieter W. Troost, Robert Lindeboom, Imke Christiaans, Thomas Grisso, Johannes B. van Goudoever, Ramón J. L. Lindauer

Published in: Journal of Genetic Counseling | Issue 6/2015

Login to get access

Abstract

Knowledge on children’s capacities to consent to medical treatment is limited. Also, age limits for asking children’s consent vary considerably between countries. Decision-making on predictive genetic testing (PGT) is especially complicated, considering the ongoing ethical debate. In order to examine just age limits for alleged competence to consent in children, we evaluated feasibility of a standardized assessment tool, and investigated cutoff ages for children’s competence to consent to PGT. We performed a pilot study, including 17 pediatric outpatients between 6 and 18 years at risk for an autosomal dominantly inherited cardiac disease, eligible for predictive genetic testing. The reference standard for competence was established by experts trained in the relevant criteria for competent decision-making. The MacArthur Competence Assessment Tool for Treatment (MacCAT-T) served as index test. Data analysis included raw agreement between competence classifications, difference in mean ages between children judged competent and judged incompetent, and estimation of cutoff ages for judgments of competence. Twelve (71 %) children were considered competent by the reference standard, and 16 (94 %) by the MacCAT-T, with an overall agreement of 76 %. The expert judgments disagreed in most cases, while the MacCAT-T judgments agreed in 65 %. Mean age of children judged incompetent was 9.3 years and of children judged competent 12.1 years (p = .035). With 90 % sensitivity, children younger than 10.0 years were judged incompetent, with 90 % specificity children older than 11.8 years were judged competent. Feasibility of the MacCAT-T in children is confirmed. Initial findings on age cutoffs are indicative for children between the age of 12 and 18 to be judged competent for involvement in the informed consent process. Future research on appropriate age-limits for children’s alleged competence to consent is needed.
Literature
go back to reference American Academy of Pediatrics Committee on Bioethics. (1995). Informed consent, parental permission, and assent in pediatric practice. Pediatrics, 95, 314–317. American Academy of Pediatrics Committee on Bioethics. (1995). Informed consent, parental permission, and assent in pediatric practice. Pediatrics, 95, 314–317.
go back to reference Appelbaum, P. S. (2007). Clinical practice. Assessment of patients’ competence to consent to treatment. The New England Journal of Medicine, 357, 1834–1840.CrossRefPubMed Appelbaum, P. S. (2007). Clinical practice. Assessment of patients’ competence to consent to treatment. The New England Journal of Medicine, 357, 1834–1840.CrossRefPubMed
go back to reference Aydin, E. R., & Sehiralti, M. (2014). Comparing assessments of the decision-making competencies of psychiatric inpatients as provided by physicians, nurses, relatives and an assessment tool. Journal of Medical Ethics, 40, 453–457.CrossRef Aydin, E. R., & Sehiralti, M. (2014). Comparing assessments of the decision-making competencies of psychiatric inpatients as provided by physicians, nurses, relatives and an assessment tool. Journal of Medical Ethics, 40, 453–457.CrossRef
go back to reference Borry, P., Evers-Kiebooms, G., Cornel, M. C., Clarke, A., & Dierickx, K. (2009). Genetic testing in asymptomatic minors: background considerations towards ESHG Recommendations. European Journal of Human Genetics, 17, 711–719.PubMedCentralCrossRefPubMed Borry, P., Evers-Kiebooms, G., Cornel, M. C., Clarke, A., & Dierickx, K. (2009). Genetic testing in asymptomatic minors: background considerations towards ESHG Recommendations. European Journal of Human Genetics, 17, 711–719.PubMedCentralCrossRefPubMed
go back to reference Buchanan, A. E., & Brock, D. W. (1990). Deciding for others: The ethics of surrogate decision making. Cambridge [U.K.]; New York: Cambridge University Press. Buchanan, A. E., & Brock, D. W. (1990). Deciding for others: The ethics of surrogate decision making. Cambridge [U.K.]; New York: Cambridge University Press.
go back to reference Charron, P., Arad, M., Arbustini, E., Basso, C., Bilinska, Z., Elliott, P., et al. (2010). Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European Heart Journal, 31, 2715–2726.CrossRefPubMed Charron, P., Arad, M., Arbustini, E., Basso, C., Bilinska, Z., Elliott, P., et al. (2010). Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European Heart Journal, 31, 2715–2726.CrossRefPubMed
go back to reference Chenneville, T., Machacek, M., Tan, R., Lujan-Zilberman, J., Emmanuel, P., & Rodriguez, C. (2014). Decisional capacity among youth with HIV: results from the MacArthur Competence Tool for Treatment. AIDS Patient Care and STDs, 28, 425–432.CrossRefPubMed Chenneville, T., Machacek, M., Tan, R., Lujan-Zilberman, J., Emmanuel, P., & Rodriguez, C. (2014). Decisional capacity among youth with HIV: results from the MacArthur Competence Tool for Treatment. AIDS Patient Care and STDs, 28, 425–432.CrossRefPubMed
go back to reference Christiaans, I., Birnie, E., Bonsel, G. J., Wilde, A. A., & van Langen, I. (2008). Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy. European Journal of Human Genetics, 16, 1201–1207.CrossRefPubMed Christiaans, I., Birnie, E., Bonsel, G. J., Wilde, A. A., & van Langen, I. (2008). Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy. European Journal of Human Genetics, 16, 1201–1207.CrossRefPubMed
go back to reference de Vries, M. C., Wit, J. M., Engberts, D. P., Kaspers, G. J. L., & Van Leeuwen, E. (2010). Norms versus practice: pediatric oncologists’ attitudes towards involving adolescents in decision making concerning research participation. Pediatric Blood & Cancer, 55, 123–128. de Vries, M. C., Wit, J. M., Engberts, D. P., Kaspers, G. J. L., & Van Leeuwen, E. (2010). Norms versus practice: pediatric oncologists’ attitudes towards involving adolescents in decision making concerning research participation. Pediatric Blood & Cancer, 55, 123–128.
go back to reference European Society of Human Genetics. (2009). Genetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics. European Journal of Human Genetics, 17, 720–721.CrossRef European Society of Human Genetics. (2009). Genetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics. European Journal of Human Genetics, 17, 720–721.CrossRef
go back to reference Grisso, T., Appelbaum, P. S., & Hill-Fotouhi, C. (1997). The MacCAT-T: a clinical tool to assess patients’ capacities to make treatment decisions. Psychiatric Services, 48, 1415–1419.CrossRefPubMed Grisso, T., Appelbaum, P. S., & Hill-Fotouhi, C. (1997). The MacCAT-T: a clinical tool to assess patients’ capacities to make treatment decisions. Psychiatric Services, 48, 1415–1419.CrossRefPubMed
go back to reference Heart Rhythm Society (HRS), & European Heart Rhythm Association (EHRA). (2011). HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies. Europace, 13, 1077–1109.CrossRef Heart Rhythm Society (HRS), & European Heart Rhythm Association (EHRA). (2011). HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies. Europace, 13, 1077–1109.CrossRef
go back to reference Hein, I. M., Troost, P. W., Lindeboom, R., de Vries, M. C., Zwaan, C. M., & Lindauer, R. J. (2012). Assessing children’s competence to consent in research by a standardized tool: a validity study. BMC Pediatrics, 12, 156.PubMedCentralCrossRefPubMed Hein, I. M., Troost, P. W., Lindeboom, R., de Vries, M. C., Zwaan, C. M., & Lindauer, R. J. (2012). Assessing children’s competence to consent in research by a standardized tool: a validity study. BMC Pediatrics, 12, 156.PubMedCentralCrossRefPubMed
go back to reference Hein, I. M., Daams, J., Troost, P. W., Lindeboom, R., & Lindauer, R. J. L. (2014a). Accuracy of assessment instruments for patients’ competence to consent to medical treatment or research. (Protocol). Cochrane Database of Systematic Reviews (5). Hein, I. M., Daams, J., Troost, P. W., Lindeboom, R., & Lindauer, R. J. L. (2014a). Accuracy of assessment instruments for patients’ competence to consent to medical treatment or research. (Protocol). Cochrane Database of Systematic Reviews (5).
go back to reference Hein, I. M., Troost, P. W., Lindeboom, R., Benninga, M. A., Zwaan, C. M., van Goudoever, J. B., et al. (2014b). Accuracy of the MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR) for measuring children’s competence to consent to clinical research. JAMA Pediatrics, 168, 1147–1153.CrossRefPubMed Hein, I. M., Troost, P. W., Lindeboom, R., Benninga, M. A., Zwaan, C. M., van Goudoever, J. B., et al. (2014b). Accuracy of the MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR) for measuring children’s competence to consent to clinical research. JAMA Pediatrics, 168, 1147–1153.CrossRefPubMed
go back to reference Hein, I. M., Troost, P. W., Broersma, A., de Vries, M. C., Daams, J. G., & Lindauer, R. J. (2015). Why is it hard to make progress in assessing children’s decision-making competence? BMC Medical Ethics, 16, 1.PubMedCentralCrossRefPubMed Hein, I. M., Troost, P. W., Broersma, A., de Vries, M. C., Daams, J. G., & Lindauer, R. J. (2015). Why is it hard to make progress in assessing children’s decision-making competence? BMC Medical Ethics, 16, 1.PubMedCentralCrossRefPubMed
go back to reference Lashley, F. R. (1999). Genetic testing, screening, and counseling issues in cardiovascular disease. The Journal of Cardiovascular Nursing, 13, 110–126.CrossRefPubMed Lashley, F. R. (1999). Genetic testing, screening, and counseling issues in cardiovascular disease. The Journal of Cardiovascular Nursing, 13, 110–126.CrossRefPubMed
go back to reference Lind, C., Anderson, B., & Oberle, K. (2003). Ethical issues in adolescent consent for research. Nursing Ethics, 10, 504–511.CrossRefPubMed Lind, C., Anderson, B., & Oberle, K. (2003). Ethical issues in adolescent consent for research. Nursing Ethics, 10, 504–511.CrossRefPubMed
go back to reference Priori, S. G., Napolitano, C., & Schwartz, P. J. (1999). Low penetrance in the long-QT syndrome: clinical impact. Circulation, 99, 529–533.CrossRefPubMed Priori, S. G., Napolitano, C., & Schwartz, P. J. (1999). Low penetrance in the long-QT syndrome: clinical impact. Circulation, 99, 529–533.CrossRefPubMed
go back to reference Priori, S. G., Napolitano, C., Memmi, M., Colombi, B., Drago, F., Gasparini, M., et al. (2002). Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation, 106, 69–74.CrossRefPubMed Priori, S. G., Napolitano, C., Memmi, M., Colombi, B., Drago, F., Gasparini, M., et al. (2002). Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation, 106, 69–74.CrossRefPubMed
go back to reference Ross, L. F., Saal, H. M., David, K. L., & Anderson, R. R. (2013). Technical report: ethical and policy issues in genetic testing and screening of children. Genetics in Medicine, 15, 234–245.CrossRefPubMed Ross, L. F., Saal, H. M., David, K. L., & Anderson, R. R. (2013). Technical report: ethical and policy issues in genetic testing and screening of children. Genetics in Medicine, 15, 234–245.CrossRefPubMed
go back to reference Schachter, D., Tharmalingam, S., & Kleinman, I. (2011). Informed consent and stimulant medication: adolescents’ and parents’ ability to understand information about benefits and risks of stimulant medication for the treatment of attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 21, 139–148.CrossRefPubMed Schachter, D., Tharmalingam, S., & Kleinman, I. (2011). Informed consent and stimulant medication: adolescents’ and parents’ ability to understand information about benefits and risks of stimulant medication for the treatment of attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 21, 139–148.CrossRefPubMed
go back to reference Shaw, M. (2001). Competence and consent to treatment in children and adolescents. Advances in Psychiatric Treatment, 7, 150–159.CrossRef Shaw, M. (2001). Competence and consent to treatment in children and adolescents. Advances in Psychiatric Treatment, 7, 150–159.CrossRef
go back to reference Smets, E. M., Stam, M. M., Meulenkamp, T. M., van Langen, I., Wilde, A. A., Wiegman, A., et al. (2008). Health-related quality of life of children with a positive carrier status for inherited cardiovascular diseases. American Journal of Medical Genetics. Part A, 146A, 700–707.CrossRefPubMed Smets, E. M., Stam, M. M., Meulenkamp, T. M., van Langen, I., Wilde, A. A., Wiegman, A., et al. (2008). Health-related quality of life of children with a positive carrier status for inherited cardiovascular diseases. American Journal of Medical Genetics. Part A, 146A, 700–707.CrossRefPubMed
go back to reference Stultiens, L., Goffin, T., Borry, P., Dierickx, K., & Nys, H. (2007). Minors and informed consent: a comparative approach. European Journal of Health Law, 14, 21–46.CrossRefPubMed Stultiens, L., Goffin, T., Borry, P., Dierickx, K., & Nys, H. (2007). Minors and informed consent: a comparative approach. European Journal of Health Law, 14, 21–46.CrossRefPubMed
go back to reference Tichnell, C., James, C. A., Murray, B., Tandri, H., Sears, S. F., & Calkins, H. (2014). Cardiology patient page. Patient’s guide to arrhythmogenic right ventricular dysplasia/cardiomyopathy: past to present. Circulation, 130, e89–e92.CrossRefPubMed Tichnell, C., James, C. A., Murray, B., Tandri, H., Sears, S. F., & Calkins, H. (2014). Cardiology patient page. Patient’s guide to arrhythmogenic right ventricular dysplasia/cardiomyopathy: past to present. Circulation, 130, e89–e92.CrossRefPubMed
go back to reference Turrell, S. L., Peterson-Badali, M., & Katzman, D. K. (2011). Consent to treatment in adolescents with anorexia nervosa. The International Journal of Eating Disorders, 44, 703–707.CrossRefPubMed Turrell, S. L., Peterson-Badali, M., & Katzman, D. K. (2011). Consent to treatment in adolescents with anorexia nervosa. The International Journal of Eating Disorders, 44, 703–707.CrossRefPubMed
go back to reference Vatta, M., Dumaine, R., Antzelevitch, C., Brugada, R., Li, H., Bowles, N. E., et al. (2002). Novel mutations in domain I of SCN5A cause Brugada syndrome. Molecular Genetics and Metabolism, 75, 317–324.CrossRefPubMed Vatta, M., Dumaine, R., Antzelevitch, C., Brugada, R., Li, H., Bowles, N. E., et al. (2002). Novel mutations in domain I of SCN5A cause Brugada syndrome. Molecular Genetics and Metabolism, 75, 317–324.CrossRefPubMed
go back to reference Vellinga, A. (2006). To know or not to be. Delft: Drukkerij Nivo. Vellinga, A. (2006). To know or not to be. Delft: Drukkerij Nivo.
Metadata
Title
Feasibility of an Assessment Tool for Children’s Competence to Consent to Predictive Genetic Testing: a Pilot Study
Authors
Irma M. Hein
Pieter W. Troost
Robert Lindeboom
Imke Christiaans
Thomas Grisso
Johannes B. van Goudoever
Ramón J. L. Lindauer
Publication date
01-12-2015
Publisher
Springer US
Published in
Journal of Genetic Counseling / Issue 6/2015
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-015-9835-7

Other articles of this Issue 6/2015

Journal of Genetic Counseling 6/2015 Go to the issue